Cameron Durrant - 27 Jul 2022 Form 4 Insider Report for HUMANIGEN, INC

Role
Chief Executive Officer, Director
Signature
/s/ Henry Madrid, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
27 Jul 2022
Net transactions value
$0
Form type
4
Filing time
29 Jul 2022, 18:30:24 UTC
Previous filing
04 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HGEN Stock Option (Right to Buy) Award $0 +808,906 $0.000000 808,906 27 Jul 2022 Common Stock 808,906 $0.3800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in two equal installments on the first and second anniversaries of the grant date.